Meridian Bioscience, Inc.
Hedge Funds Holdings
Last updated:
Meridian Bioscience, Inc.‘s stocks are currently a part of 201 hedge funds’ portfolios, which represents 97.41% of the total amount of its stocks outstanding. This makes up a total of 42.88M shares of Meridian Bioscience, Inc.. Compared to the previous quarter, the number grew by 4.42% or 1.81M shares more. As for the holding position changes, 29.85% (60) of current hedge fund investors increased the number of shares held, 32.84% (66) of current holders sold a part of the shares held, and 9.45% (19) closed the holdings completely. 45 hedge funds are new holders of Meridian Bioscience, Inc. stock in Q1 2022, it is 22.39% of total holders.
Hedge funds holding Meridian Bioscience (Q2 2017 – Q1 2022)
| Q2 2017 | 168 |
|---|---|
| Q3 2017 | 171 |
| Q4 2017 | 176 |
| Q1 2018 | 182 |
| Q2 2018 | 174 |
| Q3 2018 | 173 |
| Q4 2018 | 186 |
| Q1 2019 | 177 |
| Q2 2019 | 164 |
| Q3 2019 | 159 |
| Q4 2019 | 163 |
| Q1 2020 | 162 |
| Q2 2020 | 187 |
| Q3 2020 | 185 |
| Q4 2020 | 188 |
| Q1 2021 | 211 |
| Q2 2021 | 186 |
| Q3 2021 | 175 |
| Q4 2021 | 176 |
| Q1 2022 | 201 |
Hedge funds changes in Meridian Bioscience positions (Q2 2017 – Q1 2022)
| Q2 2017 | 26 | 57 | 47 | 19 | 19 |
|---|---|---|---|---|---|
| Q3 2017 | 20 | 60 | 51 | 17 | 23 |
| Q4 2017 | 30 | 58 | 52 | 24 | 12 |
| Q1 2018 | 26 | 66 | 57 | 17 | 16 |
| Q2 2018 | 16 | 69 | 49 | 21 | 19 |
| Q3 2018 | 17 | 61 | 62 | 16 | 17 |
| Q4 2018 | 33 | 58 | 67 | 19 | 9 |
| Q1 2019 | 17 | 80 | 46 | 27 | 7 |
| Q2 2019 | 31 | 53 | 49 | 39 | -8 |
| Q3 2019 | 19 | 61 | 55 | 23 | 1 |
| Q4 2019 | 24 | 62 | 50 | 19 | 8 |
| Q1 2020 | 29 | 51 | 58 | 30 | -6 |
| Q2 2020 | 52 | 58 | 55 | 27 | -5 |
| Q3 2020 | 35 | 64 | 59 | 33 | -6 |
| Q4 2020 | 28 | 69 | 58 | 25 | 8 |
| Q1 2021 | 47 | 68 | 74 | 22 | 0 |
| Q2 2021 | 21 | 61 | 73 | 46 | -15 |
| Q3 2021 | 21 | 46 | 71 | 28 | 9 |
| Q4 2021 | 28 | 47 | 66 | 29 | 6 |
| Q1 2022 | 45 | 60 | 66 | 19 | 11 |
Hedge funds changes in Meridian Bioscience stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 667,000 | 414,000 |
|---|---|---|
| Q3 2017 | 262,000 | 153,000 |
| Q4 2017 | 1,116,000 | 141,000 |
| Q1 2018 | 1,052,000 | 581,000 |
| Q2 2018 | 2,127,000 | 281,000 |
| Q3 2018 | 1,309,000 | 167,000 |
| Q4 2018 | 2,249,000 | 171,000 |
| Q1 2019 | 1,987,000 | 60,000 |
| Q2 2019 | 569,000 | 226,000 |
| Q3 2019 | 282,000 | 0 |
| Q4 2019 | 139,000 | 170,000 |
| Q1 2020 | 502,000 | 458,000 |
| Q2 2020 | 3,860,000 | 1,043,000 |
| Q3 2020 | 2,701,000 | 1,647,000 |
| Q4 2020 | 2,707,000 | 1,727,000 |
| Q1 2021 | 6,294,000 | 130,009,504,000 |
| Q2 2021 | 5,919,000 | 9,644,000 |
| Q3 2021 | 7,005,000 | 7,480,000 |
| Q4 2021 | 5,012,000 | 3,145,000 |
| Q1 2022 | 5,953,000 | 1,583,000 |